Paper Details

  1. Home
  2. Paper Details

[Supervised off-label prescribing of methylphenidate in adult ADHD].

Author: AmadA, BordetR, BrigadeauF, CartonL, CottencinO, DanelT, DeheulS, DevosD, DondaineT, GautierS, MarquiéC, MénardO

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This article discusses the use of methylphenidate, a stimulant medication, to treat ADHD in adults. While methylphenidate is not officially approved for this use in France, it is often prescribed off-label. The authors propose a framework for using methylphenidate in adults with ADHD, involving a multidisciplinary approach with careful monitoring and follow-up.
Paper Details　
Original Abstract of the Article :
Off-label prescription is a common practice in psychiatry, raising health and economic concerns. Collegial consultation could allow a framed prescription of treatments that are not authorized in specific indications. Attention Deficit Hyperactivity in adult populations (ADHD) is a striking example o...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.encep.2018.05.008

データ提供：米国国立医学図書館（NLM）

The ADHD Desert: Navigating Off-Label Prescribing

Attention deficit hyperactivity disorder (ADHD), a complex neurodevelopmental disorder, is like a wandering sandstorm in the desert of our brains. This study, a journey into the world of off-label prescribing, explored the challenges and potential solutions for treating ADHD in adults. It's like trying to find the right oasis in a vast desert, where the same treatment might not always work for everyone.

The Off-Label Dilemma: When Prescriptions Stray

Off-label prescribing, the use of medications for conditions other than those approved by regulatory agencies, is like navigating a desert without a map, sometimes leading to uncharted territory. This study focused on the use of methylphenidate, a medication commonly prescribed for ADHD, in adult populations.

Finding the Right Oasis: A Framework for Off-Label Prescribing

The researchers proposed a multidisciplinary framework for off-label prescribing of methylphenidate in adult ADHD, providing a roadmap through the desert of off-label use. This framework emphasizes the importance of careful diagnosis, informed consent, and ongoing monitoring to ensure safe and effective treatment.

Dr. Camel's Conclusion

This study sheds light on the complexities of off-label prescribing, particularly in the context of ADHD. The researchers advocate for a structured approach to this practice, emphasizing the importance of collaboration, patient education, and ongoing monitoring to ensure appropriate and ethical treatment.

Date :
  1. Date Completed 2019-06-10
  2. Date Revised 2019-06-13
Further Info :

Pubmed ID

30122296

DOI: Digital Object Identifier

10.1016/j.encep.2018.05.008

SNS
PICO Info
in preparation
Languages

French

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.